092040 Stock Chart & Stats
₩1115.00
-₩26.00(-2.28%)
―
--
Day’s Range― - ―
52-Week Range₩1,088.00 - ₩4,400.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)1.09M
Market Cap
₩80.39B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.17
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding70,655,390
10 Day Avg. Volume528,746
30 Day Avg. Volume1,088,208
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)₩10.00T>
092040 FAQ
What was Amicogen, Inc.’s price range in the past 12 months?
Amicogen, Inc. lowest stock price was ₩1088.00 and its highest was ₩4400.00 in the past 12 months.
What is Amicogen, Inc.’s market cap?
Amicogen, Inc.’s market cap is ₩80.39B.
When is Amicogen, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Amicogen, Inc.’s earnings last quarter?
Amicogen, Inc. released its earnings results on May 14, 2026. The company reported ₩314.508 earnings per share for the quarter, beating the consensus estimate of N/A by ₩314.508.
Is Amicogen, Inc. overvalued?
According to Wall Street analysts Amicogen, Inc.’s price is currently Undervalued.
Does Amicogen, Inc. pay dividends?
Amicogen, Inc. does not currently pay dividends.
What is Amicogen, Inc.’s EPS estimate?
Amicogen, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Amicogen, Inc. have?
Amicogen, Inc. has 70,655,390 shares outstanding.
What happened to Amicogen, Inc.’s price movement after its last earnings report?
Amicogen, Inc. reported an EPS of ₩314.508 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 2.48%.
Which hedge fund is a major shareholder of Amicogen, Inc.?
Currently, no hedge funds are holding shares in KR:092040
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cellumed Co., Ltd.
―
CORESTEMCHEMON Inc.
―
Icure Pharmaceutical Incorporation
―
Enzychem Lifesciences Corp.
―
DongKook Life Science Co., Ltd.
―